AGENDA

Mon Sep 22, 2008

Tue Sep 23, 2008

Wed Sep 24, 2008

Thu Sep 25, 2008

Fri Sep 26, 2008


DIALOGS


CHALK TALKS
Agenda Agenda



Day 2  
Wednesday, September 24, 2008

8:00 am - 8:10 am


8:10 am - 8:25 am
  Review of Live Cases from Tuesday
Krishna Rocha-Singh, MD

Challenges Facing Vascular Intervention - A Hospital Administrator's Perspective
Ann L. Prestipino, MPH (Senior VP, Massachusetts General Hospital)
   


Aortic Diseases:
Aneurysms, Dissection, Renovascular

8:25 am - 8:35 am



8:35 am - 8:45 am



8:45 am - 10:00 am






10:00 am - 10:10 am



10:10 am - 10:20 am



10:20 am - 10:30 am



10:30 am - 11:00 am

11:00 am - 12:00 pm






12:00 pm - 1:30 pm

12:15 pm - 1:15 pm

1:30 pm - 1:40 pm



1:40 pm - 1:50 pm



1:50 pm - 2:00 pm


2:00 pm - 2:10 pm


2:10 pm - 2:20 pm


2:20 pm - 2:30 pm



2:30 pm - 3:30 pm






3:30 pm - 4:00 pm

4:00 pm - 4:30 pm




4:30 pm - 5:30 pm





5:30 pm

6:00 pm - 8:00 pm

  Reimbursement and Regulatory Challenges in Endovascular Therapy: Current Challenges and Next Steps
Barry Katzen, MD

The Current Status of Endografts for AAA - Are There Any Credible Reasons to Consider Open Aneurysm Repair?
Chris Kwolek, MD

LIVE CASE DEMONSTRATIONS FROM UC DAVIS MEDICAL CENTER AND GREENVILLE MEMORIAL HOSPITAL
Moderator: Michael Dake, MD
Panel: J. Michael Bacharach, MD; James Benenati, MD; John Elefteriades, MD; John Kaufman, MD; Chris Kwolek, MD; Peter Schneider, MD

Current Role of Screening in the Management of Thoracic Aortic Aneurysm and Dissection
John Elefteriades, MD

Endograft Treatment for Thoracic Aortic Dissection: Future Strategies We Can Expect to See
Michael Dake, MD

Visceral Artery Aneurysms: When Should These Be Treated, and How?
James Benenati, MD

Refreshment Break

LIVE CASE DEMONSTRATIONS FROM UC DAVIS MEDICAL CENTER AND GREENVILLE MEMORIAL HOSPITAL
Moderator: Jon Matsumura, MD
Panel: Ted Diethrich, MD; Barry Katzen, MD; William Gray, MD; Albert Nemcek, Jr., MD; Takao Ohki, MD, PhD; Richard Powell, MD; Dierk Scheinert, MD

Lunch/Satellite Symposia

FDA Summit

Does The CORAL Trial Really Matter, and Can We Wait for the Results?
John Rundback, MD

Renal Embolic Protection: Why Should We Treat the Kidney Any Differently Than the Brain?
Andrew Holden, MD

Treatment Options for Renal In-Stent Restenosis
Kenneth Rosenfield, MD

Techniques for Renal Artery Stenting: What is Truly State-of-the-Art?
Lindsay Machan, MD

Chronic Mesenteric Ischemia: Surgery or Stent?
Richard Powell, MD

Rescue from the Acute Complications of Visceral Artery Intervention: Perforation, Dissection, Thrombosis
Robert Bersin, MD

LIVE CASE DEMONSTRATIONS FROM PRESBYTERIAN HEART INSTITUTE AND GREENVILLE MEMORIAL HOSPITAL
Moderator: Michael R. Jaff, DO
Panel: David Buckles, PhD; Mark Burket, MD; William Gray, MD; Norman Hertzer, MD; Andrew Holden, MD; Alan Matsumoto, MD; Manish Mehta, MD

Refreshment Break

Perspectives: Who Is To Blame for the Precarious State of Renal Artery Stenting?
    - An FDA Perspective: David Buckles, PhD
    - A Physician's Perspective: John Kaufman, MD

LIVE CASE DEMONSTRATIONS FROM PRESBYTERIAN HEART INSTITUTE AND GREENVILLE MEMORIAL HOSPITAL
Moderator: James Joye, DO
Panel: Mark Burket, MD; Barry Katzen, MD; Chris Kwolek, MD; Mark Mewissen, MD; Peter Schneider, MD; Mitchell Silver, DO

Day Two Concludes

The VIVA Gala



© Copyright 2008 - VIVA Physicians